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An essential role of Ffar2 (Gpr43) in dietary fibre-mediated
promotion of healthy composition of gut microbiota and
suppression of intestinal carcinogenesis
S Sivaprakasam1,2, A Gurav1, AV Paschall1, GL Coe1, K Chaudhary3, Y Cai1, R Kolhe4, P Martin1, D Browning1, L Huang3, H Shi1,3,
H Sifuentes5, M Vijay-Kumar6, SA Thompson5, DH Munn3,7, A Mellor8, TL McGaha9, P Shiao10, CW Cutler11, K Liu1, V Ganapathy2,
H Li1 and N Singh1,3
Composition of the gut microbiota has profound effects on intestinal carcinogenesis. Diet and host genetics play critical roles in
shaping the composition of gut microbiota. Whether diet and host genes interact with each other to bring specific changes in gut
microbiota that affect intestinal carcinogenesis is unknown. Ability of dietary fibre to specifically increase beneficial gut microbiota
at the expense of pathogenic bacteria in vivo via unknown mechanism is an important process that suppresses intestinal
inflammation and carcinogenesis. Free fatty acid receptor 2 (FFAR2 or GPR43) is a receptor for short-chain fatty acids (acetate,
propionate and butyrate), metabolites of dietary fibre fermentation by gut microbiota. Here, we show FFAR2 is down modulated
in human colon cancers than matched adjacent healthy tissue. Consistent with this, Ffar2−/− mice are hypersusceptible to
development of intestinal carcinogenesis. Dietary fibre suppressed colon carcinogenesis in an Ffar2-dependent manner. Ffar2
played an essential role in dietary fibre-mediated promotion of beneficial gut microbiota, Bifidobacterium species (spp) and
suppression of Helicobacter hepaticus and Prevotellaceae. Moreover, numbers of Bifidobacterium is reduced, whereas those of
Prevotellaceae are increased in human colon cancers than matched adjacent normal tissue. Administration of Bifidobacterium
mitigated intestinal inflammation and carcinogenesis in Ffar2−/− mice. Taken together, these findings suggest that interplay
between dietary fibre and Ffar2 play a key role in promoting healthy composition of gut microbiota that stimulates intestinal
health.
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INTRODUCTION
Decreased intake of dietary fibre in modern era is associated with
increased risk of colon cancers. Dietary fibre is fermented in the
colon by gut microbiota into short-chain fatty acids (SCFAs;
acetate, propionate and butyrate). SCFAs, specifically butyrate is
well known for its anti-inflammatory and anti-carcinogenic effects
in the gut.1 Butyrate enemas are known to suppress inflammation
during ulcerative colitis, a risk factor for development of colorectal
cancers.1 Moreover, recent studies demonstrate a reduction in
butyrate-producing bacteria in feces of individuals with ulcerative
colitis and colon cancers than healthy individuals.2,3 This
comparison may lead to inadequate information because there
are several variables that are known to influence composition of
gut microbiota that differ between healthy and colon cancer
subjects such as genetic make up, lifestyle, age of individuals,
dietary habits and therapeutic treatment. Therefore, an alternative
method such as comparison between cancerous tissue and
adjacent normal tissue may yield better information regarding
role of different gut bacteria in promotion or suppression of colon
cancers.
SCFAs interact with G-protein-coupled receptors 41 (GPR41 or
FFAR1), FFAR2 and HCAR2 (also known as NIACR1 or GPR109A).
FFAR1 and FFAR2 interact with all three SCFAs, whereas HACR2
interacts with butyrate only.4,5 SCFAs are involved in homeostasis
of regulatory T cells (Treg cells) in colon and modulation of
intestinal carcinogenesis.6–11 Ffar2−/− mice reveal altered suscept-
ibility to allergic airway inflammation in lung and colonic
inflammation induced by dextran sulfate sodium (DSS), ethanol
or trinitrobenzoic sulfonic acid.12–15 FFAR2 expression in colon
cancer cell lines promotes their apoptosis.16 However, the role of
Ffar2 in regulation of intestinal carcinogenesis and underlying
mechanism in vivo has not been investigated.
Fermentable dietary fibre (prebiotics) and Bifidobacterium spp
(probiotics) improve gut epithelial barrier function, prevent
apoptosis of intestinal epithelial cells, and suppress intestinal
inflammation and carcinogenesis.17–23 In vitro studies using mixed
cultures have shown that dietary fibre support growth of
divergent groups of colonic bacteria such as Clostridium,
Bifidobacteria, Bacteroides, Enterococcus and Escherichia.24,25 In
contrast, numerous human and animal studies show that dietary
1Department of Biochemistry and Molecular Biology, Georgia Regents University, Augusta, GA, USA; 2Department of Cell Biology and Biochemistry, Texas Tech University Health
Sciences, Lubbock, TX, USA; 3Cancer Research Center, Georgia Regents University, Augusta, GA, USA; 4Department of Pathology, Georgia Regents University, Augusta, GA, USA;
5Department of Medicine, Georgia Regents University, Augusta, GA, USA; 6Departments of Nutritional Sciences & Medicine, Pennsylvania State University, Medical Center,
Hershey, PA, USA; 7Department of Pediatrics, Georgia Regents University, Augusta, GA, USA; 8Institute of Cellular Medicine, Newcastle University, Newcastle-upon-Tyne, UK;
9Department of Immunology, University of Toronto, Toronto, ON, Canada; 10College of Nursing, Georgia Regents University, Augusta, GA, USA and 11Department of Periodontics,
Georgia Regents University, Augusta, GA, USA. Correspondence: Dr N Singh, Department of Biochemistry and Molecular Biology, Georgia Regents University, Augusta, GA 30912,
USA.
E-mail: nasingh@augusta.edu
Received 12 January 2016; revised 12 April 2016; accepted 18 April 2016
Citation: Oncogenesis (2016) 5, e238; doi:10.1038/oncsis.2016.38
www.nature.com/oncsis
fibre consumption specifically and consistently promote only one
group of gut bacteria, which is Bifidobacterium spp, and repress
others such as Enterococcus, Clostridium and Eubacterium24,25
suggesting that other factors regulate bifidogenic activity of
dietary fibre in vivo.
It has been hypothesized that butyrate-producing gut bacteria
play a critical role in dietary fibre-mediated suppression of colon
carcinogenesis. However, studies show conflicting data about
abundance of butyrate-producing bacteria in feces from colon
cancers subjects than healthy individuals.2,26 Similarly, both colon
cancer-promoting and -suppressive effects of butyrate have
been observed in vivo and this phenomenon has been termed
as ‘butyrate paradox’.10,11 Fusobacterium nucleatum, which is
normally present in oral cavity of nearly all humans, has been
shown to promote colon carcinogenesis.27–29 F. nucleatum is a
butyrate producer.30 Butyrate-producing bacteria poorly utilize
dietary fibre for their growth.24,31 This may be the reason that a
recent human study found that dietary fibre failed to significantly
increase any single butyrate-producing bacterial species despite
reducing the markers associated with colon carcinogenesis.32 On
the other hand, Bifidobacterium spp are the best fermenters of
dietary fibre.24,31 Furthermore, Bifidobacterium ferment dietary
fibre into acetate and lactate, which are utilized by butyrate-
producing bacteria for growth and butyrate production and this
process is termed as cross-feeding.24,31 Therefore, if fermentation
of dietary fibre is essential in suppression of colon carcinogenesis,
being the primary fermenter of dietary fibre, Bifidobacterium must
play an important role in it. In this report, we investigated whether
Ffar2 regulates dietary fibre-mediated changes in gut microbiota
and what is the impact of these changes on intestinal
carcinogenesis. Our findings demonstrate the critical role of Ffar2
in maintaining a healthy composition of gut microbiota leading to
suppression of intestinal carcinogenesis and suggest that Ffar2
signaling could be utilized as a potential target for therapeutic
correction of gut microbiota to suppress intestinal carcinogenesis.
RESULTS
Ffar2 is downregulated in human colon cancers
To test the relevance of FFAR2 in colon cancers, FFAR2 mRNA
expression was analyzed in paired colon cancer and matched
adjacent healthy tissue by quantitative polymerase chain reaction
(qPCR). Figure 1a shows that expression of FFAR2 mRNA was
reduced by more than twofold in 71% (10 out of 14) of the colon
cancers than adjacent normal tissue. When data was pooled for
these samples, FFAR2 expression was still significantly down-
regulated (by ~ 60%) in colon cancers than adjacent normal tissue
(Figure 1b) (Po0.0001). Similarly, expression of FFAR3 mRNA was
also downregulated in colon cancer samples (Supplementary
Figure 1). Same set of colon cancer samples as used in current
study also exhibits decreased expression of HCAR2 (GPR109A).33
Ffar2 suppresses inflammation-associated colon carcinogenesis
Since Ffar2 was downregulated in colon cancers, an inflammation-
associated colon carcinogenesis model was used to test the role of
Ffar2 in colonic inflammation and carcinogenesis. Ffar2−/− mice
and their wild-type (WT) littermates were injected with the colon-
specific carcinogen azoxymethane (AOM) intraperitoneally (i.p.)
followed by two cycles of DSS in drinking water as shown in
Figure 2a. All the WT littermates treated with AOM and DSS
(AOM/DSS) survived until the experimental endpoint. However,
50% of the Ffar2−/− mice died within 30 days of treatment
(Figure 2b). In contrast to WT littermates, Ffar2−/− mice exhibited
drastic reduction in body weight, and severe diarrhea during the
first cycle of DSS (Supplementary Figures 2a and b). Similarly,
higher weight loss was also observed in Ffar2−/− mice than WT
Figure 1. Expression of FFAR2 is diminished in human colon cancers. (a) Expression of FFAR2 was assessed by quantitative polymerase chain
reaction in 14 colon cancer and matched adjacent normal tissue. (b) Data from a was pooled and re-plotted. ***Po0.0001.
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counterparts during second cycle of DSS treatment
(Supplementary Figure 2a). Following AOM/DSS treatment, colons
of Ffar2−/− mice exhibited drastically increased loss of epithelium,
crypt structure and heightened infiltration of colonic mucosa by
immune cells relative to WT littermates resulting in higher
histopathological scores in the former group (Figure 2c and
Supplementary Figure 2c). Following oral gavage of fluorescein
isothiocyanate (FITC)-dextran to AOM/DSS treated animals,
sixfold more FITC-dextran was translocated to systemic circulation
of Ffar2−/− mice than WT littermates, revealing increased
gut epithelial barrier dysfunction in former group (Figure 2d).
Consistent with these findings, staining with claudin-3, a tight
junction protein revealed denudation of epithelium following
AOM/DSS treatment in Ffar2−/− mice (Supplementary Figure 2d).
In addition, colons of AOM/DSS treated Ffar2−/− mice exhibited
significantly higher weight per centimeter length than WT
littermates, presumably due to thickening of colon in Ffar2−/−
mice (Supplementary Figure 2e). Expression of several pro-
inflammatory molecules such as IL-1β, IL-17a, Ccl-2, Cox-2,
Cxcl-1, Cxcl-2 and IL-12 that promote colonic inflammation was
significantly increased in colons of Ffar2−/− mice than WT mice
after AOM/DSS treatment (Supplementary Figure 3). At the
experimental endpoint, colons of mice were harvested, opened
longitudinally and analyzed for number of polyps. Colons of AOM/
DSS treated Ffar2−/− mice had ~ 4.5 time more number of polyps
than WT littermates mice (Figures 2e–f). In addition, polyps in
colons of Ffar2−/− mice were larger in size than WT littermates
(Supplementary Figure 2f). Collectively, these data demonstrate
that Ffar2 is a key receptor that suppresses inflammation-
associated colon carcinogenesis.
Ffar2 controls intestinal carcinogenesis in ApcMin/+ mice
Next, we analyzed the role of Ffar2 in a genetic model of intestinal
carcinogenesis. Approximately 85% of the sporadic human colon
cancers harbor mutations in the adenomatous polyposis coli (APC)
gene.34 Heterozygous mutation in Apc that is present in ApcMin/+
mice results in expression of a truncated protein. These mice
develop of numerous polyps in small intestine and colon. We
found that Ffar2 is expressed in epithelial cells throughout
the small intestine (Figure 3a). Ffar2−/−ApcMin/+ mice developed
Figure 2. Ffar2 suppresses colon carcinogenesis. WT and Ffar2−/−mice (littermates) were fed with conventional mouse chow. (a) Experimental
model to induce inflammation-associated colon carcinogenesis. (b) Survival of WT and Ffar2−/− mice subjected to AOM/DSS treatment as
described in a (n= 8 mice). (c) A representative photograph of H&E stained cross-section of colons of untreated (UT) or AOM/DSS treated WT
and Ffar2−/− mice. Original magnification 200 ×. (d) After the completion of first cycle of DSS, mice were gavaged with FITC-dextran and 6 h
later FITC was quantified in serum (n= 5 mice per genotype). (e) A representative photographs of luminal side of colons from WT and Ffar2−/−
animals on day 70 after AOM/DSS treatment. (f) Polyp burden in WT and Ffar2−/−mice after AOM/DSS treatment (n= 6 mice). A representative
or pooled data from 2 experiments are shown. Error bars represent standard deviation. **Po0.002.
Figure 3. Ffar2 regulates tumorigenesis in ApcMin/+ mice. (a) Ffar2 mRNA expression by colonic and small intestinal epithelium (n= 3 mice).
A representative of two experiments is shown. (b) Polyp burden in colon and small intestine of ApcMin/+ (n= 7) and Ffar2−/− ApcMin/+ mice
(n= 6). *Po0.01, **Po0.002.
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significantly more polyps in colon than ApcMin/+ mice (Figure 3b).
SCFAs are generated in the cecum and colon, and therefore it has
been hypothesized that they will inhibit carcinogenesis only in the
cecum and colon. However, the concentrations of SCFAs in ileum
is ~ 10 mM.35 Ec50 of SCFA to induce Ca++ flux or GDP to GTP
exchange via Ffar2 is o1 mM,4 therefore it is highly possible that
at steady state there is spontaneous signaling via Ffar2 in small
intestine. At 5 month of age, Ffar2−/−ApcMin/+ mice developed
significantly more polyps in small intestine than age matched
ApcMin/+ mice (Figure 3b). These data demonstrate that Ffar2
signaling regulates development of intestinal carcinogenesis
induced by germ line mutation of Apc.
Decreased numbers of Bifidobacterium spp and increased
numbers of Prevotellaceae and H. hepaticus in gut microbiota of
Ffar2−/− mice
Numerous studies have documented that gut microbiota
dysbiosis enhances risk for development of intestinal inflammation
and cancers.2,3,19,36 We hypothesized that gut microbiota dysbiosis
enhances risk of colon carcinogenesis in Ffar2−/− mice. To test our
hypothesis, we analyzed the presence of different bacterial groups
among gut microbiota in Ffar2−/− mice and their WT littermates.
Feces of WT littermates contained ~24-fold more Bifidobacterium
spp among gut microbiota than Ffar2−/−mice (Figure 4a). Compared
with feces of WT littermates, those of Ffar2−/− mice exhibited
~1200-fold more H hepaticus (Figure 4a). Similarly, members
belonging to the Prevotellaceae family (Phylum, Bacteroidetes) were
present in significantly higher numbers in feces of Ffar2−/− mice
than WT littermates (Figure 4a). Bacterial members from phyla
Firmicutes and Bacteroidetes dominate gut microbiota.37 Firmicutes
in gut microbiota are mainly represented by members belonging to
Lactobacillus spp, Clostridium leptum, segmented filamentous
bacteria and Eubacterium rectales groups.38 Feces from WT
littermates and Ffar2−/− mice contained similar frequencies of
bacteria from these groups (Supplementary Figure 4a). Similarly,
Bacteroides and mouse intestinal Bacteroides groups, both from
phylum Bacteroidetes38 were present at comparable levels in feces
of WT and Ffar2−/− littermates (Supplementary Figure 4a). In
accordance with fecal microbiota, number of Bifidobacterium was
decreased, whereas those of H hepaticus and Prevotellaceae were
increased among microbiota attached to colons of Ffar2−/− mice
than WT littermates (Supplementary Figure 4b). Comparable
numbers of bacteria belonging to Bacteroides, mouse intestinal
Bacteroides, C leptum, E rectales and Lactobacillus groups were
attached to the colons of WT and Ffar2−/− littermates
(Supplementary Figure 4b). Taken together, these data demonstrate
that the composition of gut microbiota from Ffar2−/− mice is
enriched in favor of bacteria that promote intestinal inflammation
and cancers, whereas the numbers of bacteria that suppress
intestinal inflammation and cancers are reduced.
Essential role of Ffar2 in dietary fibre-mediated promotion of
Bifidobacterium spp and decrease of Prevotellaceae and
H hepaticus among gut microbiota
Human as well as animal studies have shown that dietary fibre
consumption specifically and consistently increases number of
only Bifidobacterium spp in gut.24 We hypothesized that Ffar2
plays an obligatory role in dietary fibre-mediated promotion of
Bifidobacterium spp. To test this hypothesis, we fed Ffar2−/− mice
and their WT littermates with a fibre free (FF) or fibre plus (FP)
diets. FP diet contained 2% inulin, 2% pectin and 1% cellulose as
source of dietary fibre, whereas FF diet completely lacks dietary
fibre, otherwise all other components between these two diets
are exactly same. The composition of gut microbiota in feces
of Ffar2−/− mice and their WT littermates were evaluated 1 week
later. Fecal microbiota changed between conventional diet and FF
or FP diet (Figure 4b). Conventional diet contains many
components such as soyabean meal, ground corn, flaked corn,
Figure 4. An essential role of Ffar2 in dietary fibre-mediated promotion of Bifidobacterium and suppression of Prevotellaceae and H. hepaticus.
(a) Fecal DNA from Ffar2−/− mice and their WT littermates were evaluated for abundance of indicated gut microbiota. (b) Ffar2−/− mice and
their WT littermates maintained on conventional diet (Conv) were fed with FF or FP diets. The abundance of indicated bacterial groups in
feces was quantified 1 day before (Conv) switching the diet or after 1 week on experimental diets (FF or FP). Shown is the relative abundance
of indicated bacterial groups to that of total bacteria. *Po0.05, **Po0.01, ***Po0.0001. (n= 4 mice). A representative of two experiments
is shown.
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molasses, wheat middling, ground wheat etc. Compositions of
these components are not exactly defined. On the other hand, FF
and FP diets are made from purified and defined components.
Thus, conventional diet differs from FF or FP with respect to
several food components. Therefore, it is difficult to assign any
changes in gut microbiota from conventional diet to FF or FP diet
to a particular food component. Feces of FF diet-fed WT animals
contained ~ 17-fold less number of Bifidobacterium spp than FP
diet-fed WT littermates (Figure 4b). In sharp contrast, feces of
Ffar2−/− mice fed with either FF or FP diet contained similar
numbers of Bifidobacterium spp, which were significantly lower
than numbers present in feces of FP-fed WT littermates
(Figure 4b). Prevotellaceae and H hepaticus were present in similar
number in feces of FF-fed WT, FF- or FP-fed Ffar2−/− mice, which
was significantly higher than that present in feces of FP-fed WT
littermates (Figure 4b). In contrast, dietary fibre increased
Bacteroides in gut microbiota in an Ffar2-independent manner
(Supplementary Figure 5). Numbers of mouse intestinal Bacter-
oides and Lactobacillus spp among gut microbiota were unaf-
fected by dietary fibre content (Supplementary Figure 5).
Consistent with previous studies,39,40 abundance of E. rectales
and C. leptum group was modestly decreased by dietary fibre in
WT mice (Supplementary Figure 5). Collectively, these data
demonstrate that Ffar2 is indispensable for dietary fibre-
mediated promotion of Bifidobacterium spp and suppression of
H hepaticus and Prevotellaceae among gut microbiota.
An essential role of Ffar2 in dietary fibre-mediated suppression of
colonic inflammation and carcinogenesis
Next, role of Ffar2 in dietary-mediated suppression of colon
carcinogenesis in AOM/DSS model was tested. FF diet-fed WT
littermates exhibited dramatically more weight loss and diarrhea
than FP diet-fed counterparts, demonstrating an essential role for
dietary fibre in AOM/DSS-mediated disease (Figure 5a and
Supplementary Figure 6a). Colons of WT mice fed with FF diet
showed severe pathology with erosion of epithelial layer,
ulceration, loss of crypt structures and higher histopathological
scores than FP diet-fed counterparts (Figures 5b and c). Consistent
with this, depletion of dietary fibre led to the development of
significantly higher numbers of colonic polyps in AOM/DSS-
treated WT littermates (Figure 5d). The ability of dietary fibre to
suppress AOM/DSS-induced weight loss, diarrhea and develop-
ment of colonic polyps was dependent on Ffar2, because Ffar2−/−
mice fed with either FF or FP diets exhibited weight loss, diarrhea
and colonic polyps, which were comparable with outcomes
observed in WT littermates fed with FF diet (Figures 5a–d). Taken
together these data demonstrates a critical role of Ffar2 in
dietary fibre-mediated suppression of colonic inflammation and
carcinogenesis.
Bifidobacterium suppresses colonic inflammation and
carcinogenesis in Ffar2−/− mice
A recent study demonstrates that co-housing of Ffar2−/− mice
with WT mice attenuate DSS-induced colonic inflammation in
Ffar2−/− mice.41 This finding suggested that (1) an unknown
beneficial gut bacteria that got transferred from WT to Ffar2−/−
mice during co-housing protected Ffar2−/− mice from colonic
inflammation and (2) Ffar2−/− mice are deficient in this gut
bacteria. However, identity of this beneficial gut bacterium is
unknown. Data presented above argues in favor of Bifidobacterium
spp being these beneficial gut bacteria. Therefore, the ability of
Bifidobacteria to suppress colonic inflammation and carcino-
genesis in Ffar2−/− mice was tested. FP-fed Ffar2−/− mice were
gavaged orally with Bifidobacterium longum subsp. infantis (ATCC
15697, B infantis) and challenged with AOM/DSS as described
in Figure 6a. Number of Bifidobacterium in feces significantly
increased in mice gavaged with B. infantis than saline (Figure 6b).
B infantis significantly suppressed weight loss, diarrhea,
inflammation and development of polyps in colon of Ffar2−/−
mice (Figures 6c–f and Supplementary Figure 6b). Collectively,
these data demonstrate that Bifidobacterium deficiency enhances
risk for development of colonic inflammation and carcinogenesis
in Ffar2−/− mice.
Decreased numbers of Bifidobacterium and increased numbers of
Prevotellaceae in human colon cancers
Based on our findings above, we evaluated the presence of
Bifidobacterium and Prevotellaceae in human colon cancers and
adjacent normal tissue. Bifidobacterium spp were readily detect-
able in most (5 out of 7) of the normal tissue, whereas it was either
undetectable or present at drastically reduced numbers in
cancerous tissue than corresponding adjacent normal tissue
(Figure 7a). When all the seven paired samples were analyzed
together, significantly higher number of Bifidobacterium was
present in matched adjacent normal tissue than tumor
(Figure 7b). In contrast, Prevotellaceae was present in higher
numbers in most of the cancerous tissue than matched adjacent
normal tissue (Figure 7). Consistent with previous studies,27–29
F nucleatum was present in higher numbers in colon cancer
tissues than corresponding adjacent normal tissue (Figure 7a).
Analysis of feces from healthy and colon cancer subjects have
shown a decrease of butyrate-producing bacteria in later.
However, F nucleatum is a butyrate producer and its numbers
are increased in colon cancers than normal tissue.27–30 Therefore,
we analyzed the presence of other butyrate-producing groups,
such as C leptum and C coccoides/E rectale in colon cancers and
matched adjacent normal tissue. Surprisingly, we found that
numbers of C coccoides/E rectale group was drastically increased in
four out of seven colon cancers than adjacent normal tissue
(Supplementary Figure 7). However, we could not find a clear
correlation for abundance of C leptum or F prausnitzii between
Figure 5. An essential role of Ffar2 in dietary fibre-mediated
suppression of colonic inflammation and carcinogenesis. WT and
Ffar2−/− mice (littermates) were fed with FF and FP diets and
1 month later were injected with AOM (i.p.). After 1 week, all the
mice were given 1.5% DSS in drinking water for next 6 days. (a)
Weight loss during and after DSS treatment. (b) A representative
photograph of H&E stained cross-section of colons of mice after
first cycle of DSS as treated in a. (c) Histopathological score
(inflammation+epithelial damage) of colons from mice 4 days after
completion of DSS treatment. (d) Polyp burden in colons of
indicated mice at the end of experiment. A representative of two
experiments is shown (n= 4 mice). **Po0.01, ***Po0.0001.
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cancerous and matched normal adjacent tissue (Supplementary
Figure 7). Collectively these data demonstrate that the number of
Bifidobacterium is decreased, whereas that of Prevotellaceae is
increased in colon cancers than matched normal tissue.
DISCUSSION
In the current study, we identified decreased numbers of
Bifidobacterium spp and increased numbers of Prevotellaceae in
colon cancers than matched adjacent normal tissue. One of the
most important findings of this study is that Ffar2 is indispensable
for dietary fibre-mediated promotion of Bifidobacterium spp and
inhibition of H hepaticus and Prevotellaceae among gut microbiota.
Increase in Bifidobacterium spp in gut is not specific to the mixture
of inulin, pectin and cellulose as source of dietary fibre used in our
study, because different types of dietary fibre such as lactulose,
trans-galactooligosaccharides and fructooligosaccharides increase
Bifidobacterium spp in human gut.24,25 The effect of dietary fibre
in enhancing numbers of Bifidobacterium spp varies among
individuals.25 Based on our findings, it will be important to
investigate whether altered expression or polymorphism of Ffar2
relates to dietary fibre-mediated promotion of Bifidobacterium spp
in humans. Although host genetics and diet can independently
affect gut microbiota,42,43 our data demonstrate that interaction
between both diet and host genes also play a critical role in
influencing the composition of gut microbiota.
In contrast to comparisons between feces of healthy and colon
cancer subjects, our data comparing colon cancer and adjacent
normal tissue found an increase in butyrate-producing bacteria
belonging to E rectale group in most of the colon cancers, which is
in line with a previous study.44 F nucleatum, which is associated
with colon cancer tissue and promotes colon carcinogenesis,
is a butyrate producer. Evidences have been presented for both
tumor-promoting and -suppressing effect of butyrate in colon.10,11
Tumor-suppressing activity of butyrate has been largely attributed
to its ability to inhibit HDAC activity. At single cell level, butyrate
can induce apoptosis in colon cancer cells; however, at tissue or
organ level, continuous exposure to butyrate will lead to toxicity
towards other cells such as underlying connective tissue in colon,
which may induce inflammation and/or promote metastasis. In
fact, it has been proposed that F nucleatum produced butyrate
plays a key role in induction of plaques and pathologies in dental
tissues by inhibiting growth of fibroblast.30 Therefore, a lot of care
should be taken in to considerations, such as effects of butyrate at
tissue or organ level, effects of other cellular, molecular, metabolic
or virulence factors of butyrate-producing bacteria in evaluating
their role in colon carcinogenesis.
In summary, data presented in this study demonstrate that
Ffar2 signaling promotes intestinal health by stimulating growth
of beneficial bacteria such as Bifidobacterium and by decreasing
the number of harmful gut microbiota such as H hepaticus and
Prevotellaceae. It is evident that SCFA receptors Ffar2 and Hcar2
induce non-redundant mechanisms such as inflammasome
activation, homeostasis of colonic Treg cells and promoting a
healthy composition of gut microbiota,8–10,41 which could
explain how a defect in even one of the these receptors may
result in reduced efficacy of dietary fibre to suppress intestinal
carcinogenesis. A better understanding of all the signaling
pathways induced by SCFA and dietary fibre will be useful in
designing precise and better therapeutic strategies to prevent
and/or treat intestinal inflammation and cancers.
MATERIALS AND METHODS
Mice and diets
C57BL/6J mice were obtained from Jackson laboratory. Ffar2+/− mice on
C57BL/6 background were obtained from Deltagen. Ffar2+/− mice were
bred to obtain Ffar2−/− mice. Both males and females of ages between
3 and 6 months were used in study. Animals were maintained on
conventional rodent chow, TD-8604 (Harlan Laboratories, Madison, WI,
USA) unless stated. FF (TD-00278) and FP (TD-130715) mouse chows were
purchased from Harlan Laboratories. Formulation for FF diet is as follows:
Lactalbumin 20.5%, DL-Methionine 0.22%, Dextrose monohydrate
52.839%, Maltodextrin 15%, Soybean Oil 5%, Mineral Mix AIN-93G 3.5%,
Vitamin Mix AIN-93 1.5%, Potassium phosphate monobasic 0.84%, Calcium
carbonate 0.3%, Choline Bitartrate 0.3% and TBHQ antioxidant 0.001%. FP
diet is similar to FF diet, with 5% dietary fibre (1% cellulose, 2% pectin and
2% inulin) added. Bifidobacterium longum subsp. Infantis ATCC 15697 (B
infantis) was purchased from American Type Culture Collection (ATCC).
Where indicated, mice were gavaged orally with 2 × 108 CFU of B infantis
Figure 6. Bifidobactreia suppress colonic inflammation and carcinogenesis in Ffar2−/− mice. (a) Ffar2−/− mice fed with FP diet and 1 month
later were challenged with AOM/DSS and B. infantis as shown. B. infantis was gavaged everyday (2 × 108 cfu/mouse) as indicated from day of
AOM injection till the completion of DSS treatment. (b) Relative abundance of Bifidobacterium in mice gavaged with B. infantis or saline as in a.
Shown is the weight loss (c) during and after DSS challenge. (d) A representative photograph of H&E stained cross-section of colons of mice
4 days after cessation of DSS treatment. (e) Histopathological score (inflammation+epithelial damage) of colons. (f) Polyp burden in colons of
mice treated as described in a at experimental endpoint. A representative of two experiments is shown (n= 4 mice). *Po0.05, **Po0.01,
***Po0.0001.
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in 100 μl of sterile saline buffered with 5% sodium bicarbonate. The
Institutional Animal Care and Use Committee, Georgia Regents University
approved all animal procedures.
Colitis-associated colon cancer model
Mice were injected intraperitoneally (i.p.) with AOM, (Sigma, St Louis, MO,
USA) at dose of 10 mg/kg body weight in phosphate buffered saline. After
7 days, mice were fed 2% DSS, (MP Biochemicals, Santa Ana, CA, USA)
molecular mass 36 000–50 000 Da in the drinking water for 7 days,
followed by 15 days of regular water. This cycle was repeated twice. In
experiments involving FP or FF diet, mice received a single cycle of 1.5%
DSS in drinking water. Mice were monitored for weight changes, diarrhea
and rectal bleeding. Diarrhea was scored as (0) normal stool, (1) soft but
formed pellet, (2) very soft pellet, (3) diarrhea (no pellet) or (4) dysenteric
diarrhea. Rectal bleeding was recorded as (0) no bleeding, (2) presence of
occult blood in stool or (4) gross macroscopic bleeding. Seventy days
following AOM injection, colonic lumens of mice were evaluated for polyp
number and size.
Measurement of gut epithelial barrier function
Gut epithelial barrier function was evaluated using FITC-dextran, 4kD
(Sigma). Mice were administered an oral gavage of FITC-dextran as a
permeability tracer at a dose of 50 mg/100 g of body weight. Six hours
later, mice were bled, serum was collected and FITC-dextran in serum
was measured by fluorescence spectrophotometry (SpectraMax,
Molecular Devices, Sunnyvale, CA, USA). FITC-dextran concentration was
determined from standard curves generated by serial dilution of known
concentrations of FITC-dextran in control serum ran in parallel.
Immunohistochemistry
Colons were excised and cleaned with phosphate buffered saline followed by
fixation in neutral buffered formalin (Thermo Fisher, Waltham, MA, USA). The
fixed colon tissues were embedded in paraffin and 5 μm thick sections were
sliced and placed on glass microscope slides. Immunohistochemical staining
was performed as described previously.8 Briefly, sections were deparaffinized,
followed by antigen retrieval using the antigen retrieval solution (Agilent
Technologies, Santa Clara, CA, USA). Endogenous peroxidase activity was
quenched with 3% H2O2 in phosphate buffered saline for 10 min. Sections
were stained using specific primary antibodies and Vectastain ABC kit and
diaminobenzidine (Vector Laboratories, Burlingame, CA, USA). Counter-
staining was performed with hematoxylin and stained sections were
visualized by Leica DM550B microscope. Alternatively, in some experiments,
fluorescent dye-labeled secondary antibody was used and sections were
visualized by LSM 510 (Zeiss) confocal microscopy.
Figure 7. Decreased abundance of Bifidobacterium spp in human colon cancers. (a) Relative abundance of indicated bacterial groups in DNA
extracted from colon cancers and matched adjacent normal tissue was measured by quantitative polymerase chain reaction. (b) Relative levels
of Bifidobacterium in colon cancer and matched adjacent normal tissue. The horizontal line represents the median value. *Po0.05.
UD, undetectable. Statistical significance was calculated using Mann–Whitney test with two-tailed analysis.
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Isolation of RNA, DNA and quantitative PCR
Total RNA was extracted from colon tissue using TRIzol reagent (Thermo
Fisher). The high capacity cDNA synthesis kit (Thermo Fisher) was used for
synthesis of cDNA. Relative amounts of mRNAs were measured using
polymerase chain reaction (PCR) and StepOne Real-time PCR system
(Thermo Fisher) on cDNA samples. Gene expression was quantified using
ΔΔCT method.
Colon cancer and matched adjacent normal tissue
Anonymous human colon cancer tissue and matched adjacent normal
tissue from all demographics were obtained after informed consent and
approval from the Institutional Review Board. The samples were collected
over a period of time at Georgia Regents Medical Center Augusta, GA, USA.
PCR primer for detection of FFAR2 has been described.45
Quantification of gut microbiota
Feces (~100 mg) were suspended with 710 μl of disruption buffer (200 mM
NaCl, 200 mM Tris pH 8.0, 20 mM EDTA pH 8.0 and 6% SDS) and 500 μl of
phenol/chloroform/isoamyl alcohol, pH 8.0 inside tubes containing
Zirconium beads (0.1 mm diameter, Benchmark Scientific, Edison, NJ,
USA). The mixture was homogenized using a Beadbeater (BioSpec,
Bartlesville, OK, USA) for 2 cycles of 2 min each. Sample was centrifuged
at 7000 g for 3 min and aqueous phase was collected and a second round
of phenol/chloroform/isoamyl extraction was performed. DNA from the
clear aqueous phase was precipitated using sodium acetate and
isopropanol. Dried DNA pellet was dissolved in TE buffer. Quantitative
polymerase chain reaction using group-specific PCR primers were used to
quantify relative abundance of different groups to the total gut microbiota
as reported previously38,46,47 and the sequences of PCR primers are
provided in Supplementary Table 1.
Statistical analysis
Statistical significance was calculated using T-test with two-tailed analysis
unless stated otherwise. No method was used to predetermine the sample
size. Experiments were performed and analyzed in non-randomized and
non-blinded fashion.
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